APO RESEARCH · REPORT
Lancets
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.
Product & engineering
Understand the product.
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.
These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
Selected research
Industry Research
Lancets Industry Research Report 2026
Market perspective
Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications.
These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.
The major players in global Lancets market include Roche, Lifescan, BD, etc. The top 3 players occupy about 30% shares of the global market. Europe and North America are main markets, they occupy about 70% of the global market. Homecare Lancets is the main type, with a share about 80%. Glucose Tests is the main application, which holds a share about 70%.
Read the full market overview
Report Scope
This report quantifies the global Lancets market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lancets Market by Company
Roche
Lifescan
BD
Bayer
Abbott
B. Braun
ARKRAY
Terumo
I-SENS
Nipro
Omron
Infopia
AgaMatrix
Smiths Medical
Sarstedt
SANNUO
Yicheng
Yuwell
Greiner Bio One
Edan
Narang Medical
Lancets Segment by Type
Safety Lancets
Homecare Lancets
Lancets Segment by Application
Cholesterol Tests
Glucose Tests
Others
Lancets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lancets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lancets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lancets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lancets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lancets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lancets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Safety Lancets
- Homecare Lancets
Applications
- Cholesterol Tests
- Glucose Tests
- Others
Companies covered
- Roche
- Lifescan
- BD
- Bayer
- Abbott
- B. Braun
- ARKRAY
- Terumo
- I-SENS
- Nipro
- Omron
- Infopia
- AgaMatrix
- Smiths Medical
- Sarstedt
- SANNUO
- Yicheng
- Yuwell
- Greiner Bio One
- Edan
- Narang Medical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lancets Market Size (2021-2032)
- 2.2.2 Global Lancets Sales (2021-2032)
- 2.2.3 Global Lancets Market Average Price (2021-2032)
- 2.3 Lancets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Safety Lancets
- 2.3.3 Homecare Lancets
- 2.4 Lancets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cholesterol Tests
- 2.4.3 Glucose Tests
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lancets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lancets Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Lancets Revenue of Manufacturers (2021-2026)
- 3.4 Global Lancets Average Price by Manufacturers (2021-2026)
- 3.5 Global Lancets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lancets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lancets, Product Type & Application
- 3.8 Global Manufacturers of Lancets, Established Date
- 3.9 Global Lancets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Roche
- 4.1.1 Roche Company Information
- 4.1.2 Roche Business Overview
- 4.1.3 Roche Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Roche Lancets Product Portfolio
- 4.1.5 Roche Recent Developments
- 4.2 Lifescan
- 4.2.1 Lifescan Company Information
- 4.2.2 Lifescan Business Overview
- 4.2.3 Lifescan Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Lifescan Lancets Product Portfolio
- 4.2.5 Lifescan Recent Developments
- 4.3 BD
- 4.3.1 BD Company Information
- 4.3.2 BD Business Overview
- 4.3.3 BD Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 BD Lancets Product Portfolio
- 4.3.5 BD Recent Developments
- 4.4 Bayer
- 4.4.1 Bayer Company Information
- 4.4.2 Bayer Business Overview
- 4.4.3 Bayer Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bayer Lancets Product Portfolio
- 4.4.5 Bayer Recent Developments
- 4.5 Abbott
- 4.5.1 Abbott Company Information
- 4.5.2 Abbott Business Overview
- 4.5.3 Abbott Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Abbott Lancets Product Portfolio
- 4.5.5 Abbott Recent Developments
- 4.6 B. Braun
- 4.6.1 B. Braun Company Information
- 4.6.2 B. Braun Business Overview
- 4.6.3 B. Braun Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 B. Braun Lancets Product Portfolio
- 4.6.5 B. Braun Recent Developments
- 4.7 ARKRAY
- 4.7.1 ARKRAY Company Information
- 4.7.2 ARKRAY Business Overview
- 4.7.3 ARKRAY Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ARKRAY Lancets Product Portfolio
- 4.7.5 ARKRAY Recent Developments
- 4.8 Terumo
- 4.8.1 Terumo Company Information
- 4.8.2 Terumo Business Overview
- 4.8.3 Terumo Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Terumo Lancets Product Portfolio
- 4.8.5 Terumo Recent Developments
- 4.9 I-SENS
- 4.9.1 I-SENS Company Information
- 4.9.2 I-SENS Business Overview
- 4.9.3 I-SENS Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 I-SENS Lancets Product Portfolio
- 4.9.5 I-SENS Recent Developments
- 4.10 Nipro
- 4.10.1 Nipro Company Information
- 4.10.2 Nipro Business Overview
- 4.10.3 Nipro Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Nipro Lancets Product Portfolio
- 4.10.5 Nipro Recent Developments
- 4.11 Omron
- 4.11.1 Omron Company Information
- 4.11.2 Omron Business Overview
- 4.11.3 Omron Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Omron Lancets Product Portfolio
- 4.11.5 Omron Recent Developments
- 4.12 Infopia
- 4.12.1 Infopia Company Information
- 4.12.2 Infopia Business Overview
- 4.12.3 Infopia Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Infopia Lancets Product Portfolio
- 4.12.5 Infopia Recent Developments
- 4.13 AgaMatrix
- 4.13.1 AgaMatrix Company Information
- 4.13.2 AgaMatrix Business Overview
- 4.13.3 AgaMatrix Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 AgaMatrix Lancets Product Portfolio
- 4.13.5 AgaMatrix Recent Developments
- 4.14 Smiths Medical
- 4.14.1 Smiths Medical Company Information
- 4.14.2 Smiths Medical Business Overview
- 4.14.3 Smiths Medical Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Smiths Medical Lancets Product Portfolio
- 4.14.5 Smiths Medical Recent Developments
- 4.15 Sarstedt
- 4.15.1 Sarstedt Company Information
- 4.15.2 Sarstedt Business Overview
- 4.15.3 Sarstedt Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Sarstedt Lancets Product Portfolio
- 4.15.5 Sarstedt Recent Developments
- 4.16 SANNUO
- 4.16.1 SANNUO Company Information
- 4.16.2 SANNUO Business Overview
- 4.16.3 SANNUO Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 SANNUO Lancets Product Portfolio
- 4.16.5 SANNUO Recent Developments
- 4.17 Yicheng
- 4.17.1 Yicheng Company Information
- 4.17.2 Yicheng Business Overview
- 4.17.3 Yicheng Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Yicheng Lancets Product Portfolio
- 4.17.5 Yicheng Recent Developments
- 4.18 Yuwell
- 4.18.1 Yuwell Company Information
- 4.18.2 Yuwell Business Overview
- 4.18.3 Yuwell Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Yuwell Lancets Product Portfolio
- 4.18.5 Yuwell Recent Developments
- 4.19 Greiner Bio One
- 4.19.1 Greiner Bio One Company Information
- 4.19.2 Greiner Bio One Business Overview
- 4.19.3 Greiner Bio One Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.19.4 Greiner Bio One Lancets Product Portfolio
- 4.19.5 Greiner Bio One Recent Developments
- 4.20 Edan
- 4.20.1 Edan Company Information
- 4.20.2 Edan Business Overview
- 4.20.3 Edan Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.20.4 Edan Lancets Product Portfolio
- 4.20.5 Edan Recent Developments
- 4.21 Narang Medical
- 4.21.1 Narang Medical Company Information
- 4.21.2 Narang Medical Business Overview
- 4.21.3 Narang Medical Lancets Sales, Revenue and Gross Margin (2021-2026)
- 4.21.4 Narang Medical Lancets Product Portfolio
- 4.21.5 Narang Medical Recent Developments
5 Global Lancets Market Scenario by Region
- 5.1 Global Lancets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lancets Sales by Region: 2021-2032
- 5.2.1 Global Lancets Sales by Region: 2021-2026
- 5.2.2 Global Lancets Sales by Region: 2027-2032
- 5.3 Global Lancets Revenue by Region: 2021-2032
- 5.3.1 Global Lancets Revenue by Region: 2021-2026
- 5.3.2 Global Lancets Revenue by Region: 2027-2032
- 5.4 North America Lancets Market Facts & Figures by Country
- 5.4.1 North America Lancets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lancets Sales by Country (2021-2032)
- 5.4.3 North America Lancets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Lancets Market Facts & Figures by Country
- 5.5.1 Europe Lancets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lancets Sales by Country (2021-2032)
- 5.5.3 Europe Lancets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Lancets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lancets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lancets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lancets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lancets Market Facts & Figures by Country
- 5.7.1 South America Lancets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lancets Sales by Country (2021-2032)
- 5.7.3 South America Lancets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Lancets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lancets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lancets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lancets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Lancets Sales by Type (2021-2032)
- 6.1.1 Global Lancets Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Lancets Sales Market Share by Type (2021-2032)
- 6.2 Global Lancets Revenue by Type (2021-2032)
- 6.2.1 Global Lancets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lancets Revenue Market Share by Type (2021-2032)
- 6.3 Global Lancets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lancets Sales by Application (2021-2032)
- 7.1.1 Global Lancets Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Lancets Sales Market Share by Application (2021-2032)
- 7.2 Global Lancets Revenue by Application (2021-2032)
- 7.2.1 Global Lancets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lancets Revenue Market Share by Application (2021-2032)
- 7.3 Global Lancets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lancets Value Chain Analysis
- 8.1.1 Lancets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lancets Production Mode & Process
- 8.2 Lancets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lancets Distributors
- 8.2.3 Lancets Customers
9 Global Lancets Analyzing Market Dynamics
- 9.1 Lancets Industry Trends
- 9.2 Lancets Industry Drivers
- 9.3 Lancets Industry Opportunities and Challenges
- 9.4 Lancets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst